Sherlock Bio to buy UK firm in quest for CRISPR-based handheld…

Feb 1 (Reuters) — Privately-held Sherlock Biosciences said on Wednesday it has acquired UK-based Sense Biodetection to speed up the launch of handheld diagnostic tests that use the breakthrough CRISPR gene editing technology. Sherlock raised $80 million nearly a year ago for development of diagnostics based on the CRISPR tool, which is designed to work…

Read More

POLL-Brazil's central bank to keep wary stance against govt flak

<p website poll data By Gabriel Burin BUENOS AIRES, Jan 27 (Reuters) — Brazil’s central bank will keep a wary stance next week against strong criticism from recently elected President Luiz Inacio Lula da Silva, maintaining the Selic benchmark rate at current high levels, a Reuters poll suggests. Investors are focusing on how hawkish the…

Read More